Alcon (ALC) announced Tuesday that it terminated its definitive merger agreement with STAAR Surgical Company (STAA) announced on August 5, 2025.
Earlier today, STAAR Surgical Company announced that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon at the Special Meeting of Stockholders.
Following the announcement, which is based on preliminary estimates by STAAR's proxy solicitor, the company plans to terminate Alcon merger agreement and continue to remain a standalone, publicly traded company.
In August 2025, Alcon agreed to acquire STAAR Surgical Company for $28 per share in cash, valuing STAAR at approximately $1.5 billion in equity value.
In December 2025, Alcon announced an amended merger agreement for the acquisition of STAAR Surgical Company (STAA), intending to purchase outstanding stock of the latter for $30.75 per share in cash. The renewed price had represented an additional approximately $150 million in equity value for stockholders.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.